New Tactic for Controlling Blood Sugar in Diabetes Contradicts Current View...
Study finds inflammation may be part of the solution not the problemBOSTON Sept. 4 2011 PRNewswireUSNewswire Increased lowgrade inflammation in the body resulting from obesity is widely viewed as...
View ArticleNektar Initiates Second Phase 1 Clinical Study Evaluating NKTR181 A Novel...
SAN FRANCISCO Sept. 8 2011 PRNewswire Nektar Therapeutics Nasdaq NKTR today announced that dosing began in a Phase 1 clinical study to evaluate multiple ascending doses of NKTR181 the company's novel...
View ArticleIMMUNE Pharmaceuticals Announces Alan G. Harris MD PhD FRCP as Chief Medical...
NEW YORK Sept. 13 2011 PRNewswire IMMUNE Pharmaceuticals an emerging leader in the development of Antibody based Therapeutics for the treatment of inflammatory diseases and cancer today announced the...
View ArticleSmall Intestine Transplant Experts From Around the World Hosted by Georgetown
WASHINGTON Sept. 14 2011 PRNewswire Fiftytwo yearold Paul McNeel a fire chief from Leonardtown Maryland was 37 in 1996 when a sudden health problem caused the loss of his small intestine. Almost all of...
View ArticleNektar Therapeutics' President and CEO Howard W. Robin to Present at the UBS...
SAN FRANCISCO Sept. 14 2011 PRNewswire Nektar Therapeutics' Nasdaq NKTR President and Chief Executive Officer Howard W. Robin is scheduled to present at the upcoming UBS 2011 Global Life Sciences...
View ArticleSoligenix Announces Results of Recent Data Safety Monitoring Board Review for...
PRINCETON N.J. Sept. 15 2011 PRNewswire Soligenix Inc. OTCBB SNGX Soligenix or the Company a latestage biopharmaceutical company announced that an independent Data Safety Monitoring Board DSMB recently...
View ArticleChemoCentryx Reports CCX140B Meets Primary Endpoint and Demonstrates Clinical...
MOUNTAIN VIEW Calif. Sept. 15 2011 PRNewswire ChemoCentryx Inc. today announced that the Company's novel orally active CCR2 antagonist CCX140B demonstrated an excellent safety profile and exhibited...
View ArticleBiondo Creative Joins Crohn's & Colitis Foundation As They Kick Off Local...
PHILADELPHIA Sept. 29 2017 PRNewswire Biondo Creative will join more than 200 participants that will runwalk for cures in the Crohn's & Colitis Foundation's Bucks County Take Steps Walk on...
View ArticleACT Secures First Patent for Generating Hemangioblast Cells to Treat a Broad...
MARLBOROUGH Mass. Sept. 19 2011 PRNewswire Advanced Cell Technology Inc. "ACT"; OTCBB ACTC a leader in the field of regenerative medicine announced today that it has been issued a patent patent number...
View ArticleNektar Presents Positive Data for Novel Opioid Analgesic NKTR181 at the 2011...
SAN FRANCISCO Sept. 21 2011 PRNewswire Nektar Therapeutics NASDAQNKTR today announced that positive proofofconcept data is being presented from its first Phase 1 clinical trial of NKTR181 at the...
View ArticleHealthWell Foundation Launches Systemic Lupus Erythematosus SLE Fund
GAITHERSBURG Md. Sept. 22 2011 PRNewswire The HealthWell Foundation&174; a nonprofit organization providing financial assistance to insured patients facing a variety of chronic and lifealtering...
View ArticleREMICADEÂ Receives FDA Approval as First Biologic Treatment for Pediatric...
HORSHAM Pa. Sept. 23 2011 PRNewswire Janssen Biotech Inc. announced today that the U.S. Food and Drug Administration FDA has approved REMICADE&174; infliximab for the treatment of moderately to...
View ArticleFDA Approves Remicade to Treat Ulcerative Colitis in Children Older Than 6 Years
SILVER SPRING Md. Sept. 23 2011 PRNewswireUSNewswire The U.S. Food and Drug Administration today approved Remicade infliximab to treat moderately to severely active ulcerative colitis UC in children...
View ArticleCasey Abrams Announces Finalists in National Inflammatory Bowel Disease...
HORSHAM Pa. Sept. 29 2011 PRNewswire Season 10 American Idol contestant Casey Abrams has announced the top finalists in the national awareness campaign IBD Icons which celebrates the courage and...
View ArticleChemoCentryx Initiates Phase II Clinical Trial for CCX168 a Novel Small...
MOUNTAIN VIEW Calif. Oct. 17 2011 PRNewswire ChemoCentryx Inc. today announced the initiation of a Phase II clinical trial for CCX168 an orallyadministered small molecule for the treatment of...
View ArticlePrometheus Launches Next Generation IBD Diagnostic Test
SAN DIEGO Oct. 24 2011 PRNewswire Prometheus Laboratories Inc. a specialty pharmaceutical and diagnostic company today announced the commercial launch of its proprietary PROMETHEUS&174; IBD sgi...
View ArticleInnovative Pharmacy Leader Jeanne Ann Stasny Joins Diplomat Specialty...
FLINT Mich. Oct. 26 2011 PRNewswire Diplomat Specialty Pharmacy the nation's largest privately owned specialty pharmacy announced today that Jeanne Ann Stasny R.Ph. a highly respected industry...
View ArticleNektar to Announce Financial Results for the Third Quarter of 2011 on...
SAN FRANCISCO Oct. 26 2011 PRNewswire Nektar Therapeutics Nasdaq NKTR will announce its financial results for the third quarter ended September 30 2011 on Wednesday November 2 2011 after the close of...
View ArticleUCB Proudly Reinforces LongStanding Commitment to Patients and Physicians at...
ATLANTA Oct. 28 2011 PRNewswire UCB a leading biopharmaceutical company at the forefront of immunology treatment and research is marking the 2011 American College of Gastroenterology ACG meeting in...
View ArticleGroundbreaking Treatments Innovative Prevention Strategies and New Insights...
Fecal Transplants Hepatitis C Efficacy of Probiotics Smoking's Impact on GI Health Vitamin D in IBD Therapy Adult IBS and Childhood Trauma Link Among Featured ScienceWASHINGTON Oct. 31 2011...
View Article